Atossa Therapeutics Inc (ATOS)
1.50
+0.10
(+7.14%)
USD |
NASDAQ |
Sep 27, 16:00
1.49
-0.01
(-0.67%)
After-Hours: 19:40
Atossa Therapeutics Free Cash Flow: -18.69M for June 30, 2024
Free Cash Flow Chart
Historical Free Cash Flow Data
| Date | Value |
|---|---|
| June 30, 2024 | -18.69M |
| March 31, 2024 | -18.64M |
| December 31, 2023 | -20.96M |
| September 30, 2023 | -19.92M |
| June 30, 2023 | -21.45M |
| March 31, 2023 | -22.92M |
| December 31, 2022 | -20.79M |
| September 30, 2022 | -19.92M |
| June 30, 2022 | -17.58M |
| March 31, 2022 | -16.96M |
| December 31, 2021 | -16.48M |
| September 30, 2021 | -16.25M |
| June 30, 2021 | -15.86M |
| March 31, 2021 | -12.76M |
| December 31, 2020 | -11.58M |
| September 30, 2020 | -10.86M |
| June 30, 2020 | -9.943M |
| March 31, 2020 | -10.22M |
| December 31, 2019 | -9.136M |
| September 30, 2019 | -8.928M |
| June 30, 2019 | -9.460M |
| March 31, 2019 | -8.784M |
| December 31, 2018 | -9.072M |
| September 30, 2018 | -8.255M |
| June 30, 2018 | -7.656M |
| Date | Value |
|---|---|
| March 31, 2018 | -7.171M |
| December 31, 2017 | -6.594M |
| September 30, 2017 | -6.272M |
| June 30, 2017 | -3.934M |
| March 31, 2017 | -4.245M |
| December 31, 2016 | -5.384M |
| September 30, 2016 | -8.041M |
| June 30, 2016 | -12.21M |
| March 31, 2016 | -14.06M |
| December 31, 2015 | -14.08M |
| September 30, 2015 | -12.66M |
| June 30, 2015 | -12.20M |
| March 31, 2015 | -11.04M |
| December 31, 2014 | -10.72M |
| September 30, 2014 | -10.86M |
| June 30, 2014 | -10.84M |
| March 31, 2014 | -10.68M |
| December 31, 2013 | -9.320M |
| September 30, 2013 | -8.515M |
| June 30, 2013 | -5.617M |
| March 31, 2013 | -4.238M |
| December 31, 2012 | -3.90M |
| September 30, 2012 | -3.058M |
| June 30, 2012 | -4.267M |
| March 31, 2012 | -4.628M |
Free Cash Flow Range, Past 5 Years
-22.92M
Minimum
Mar 2023
-8.928M
Maximum
Sep 2019
-15.99M
Average
-16.72M
Median
Free Cash Flow Benchmarks
| Hologic Inc | 1.014B |
| Perspective Therapeutics Inc | -24.58M |
| Spectral AI Inc | -15.76M |
| Electromed Inc | 8.672M |
| Xtant Medical Holdings Inc | -17.52M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | -4.531M |
| Cash from Investing (Quarterly) | -0.003M |
| Cash from Financing (Quarterly) | 0.10M |
| Free Cash Flow Per Share (Quarterly) | -0.0361 |
| Free Cash Flow Yield | -9.93% |